Clinical Trial Update: Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing efficacy and safety of HGP1910 and HCP1903 in patients with primary hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• HCP1903
• HGP1910

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: COMPLETED